The markets are headed for a weak start to the day this morning. On one hand, there is the optimism of an easing of trade tensions between the U.S and China. At the beginning of the week, negotiators said there was positive progress on the trade talks. The optimism is increased by news that China […]
Stocks to Watch amidst Mixed Market Sentiment Read More »
Urban One Inc [NASDAQ: UONE] has been on a downtrend for the past month. However, it seems to have found some support at around $4 and has bounced off this price level. If it holds, the stock could see an increase in buying momentum as investors move in to take positions. This is already showing
Urban One Inc [UONE] – Why to Buy As Stock Trades At Key Support Level Read More »
The markets are up this morning driven by news that the U.S and China are making progress in their trade negotiations. According to the U.S trade negotiator Robert Lighthizer and his Chinese colleague, the two countries were fully committed to ensuring that the negotiations turn out successful. This reassurance has led to higher appetite for
Stocks to Watch as Positive U.S-China Trade News Drive-up Markets Read More »
ADMA Biologics Inc [NASDAQ: ADMA] is a top performer this afternoon. Like other companies that deal in plasma biologics, this stock has benefitted from the FDA’s approval of the use of blood plasma in the treatment of COVID-19. Yesterday, the FDA released a statement stating that it was issuing an Emergency Use Authorization for the
The markets are up this morning driven by news that the U.S had approved a COVID-19 treatment. Yesterday, the U. S FDA issued an emergency use authorization for the use of blood plasma from people who had recovered from COVID-19 as a treatment. In a statement, the FDA said that on the basis of available
High Flying Plasma Pharmaceuticals as FDA Approves Plasma-based COVID-19 Treatment Read More »
Hancock Jaffe Laboratories Inc [NASDAQ: HJLI] is in a bullish breakout at the moment. After trading in a range for months, the stock has shot up by 130%. The breakout follows the company’s announcement that follow-up data on two more VenoValve patients showed improvement compared to their condition before the surgery. The two are part
Hancock Jaffe Laboratories Inc [HJLI] – What next after Bullish breakout? Read More »
The markets are headed to a weak start this morning. This comes amidst rising concerns that the market is overvalued after the S&P 500 hit an all-time despite the ongoing pandemic. The uncertainty comes after labour data consistently showing that the U.S economy was still struggling from the effects of the COVID-19 pandemic The FOMC
Stocks to Watch as Caution Grips the Markets Read More »
GEVO Inc [NASDAQ: GEVO] is a top performer today and is up by over 200%. This comes after the company announced that it had entered into a revenue contract with Trafigura. The agreement is a long-term take or pay contract that is worth $1.5 billion and is the biggest deal in Gevo history. Under the
GEVO Inc [GEVO] – A Top Stock To Watch For The Remainder Of 2020 Read More »
It’s a weak start to the markets as investors await weak labor data from the labor department. Investors are also digesting the cautious data from the Federal Reserve about the economy. Members of the Federal Open Markets Committee are in agreement that the current health crisis could continue to weigh heavily on the U.S economy
High Potential Stocks to Watch Despite Weak Market Sentiment Read More »
9 Meters Biopharma [NASDAQ: NMTR] is showing some interesting price action. Yesterday, the stock gapped up and pushed through monthly support at $0.80. This price action came just a day after the company was highlighted at the Truist Securities Catalyst conference call. The conference call touched on preliminary phase 1 /2 data from short bowel
9 Meters Biopharma [NMTR] Breaks Monthly Resistance – Is A Rally Beckoning? Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.